Major US airlines oppose Air China bid to schedule additional US flights

Airlines for America opposed Air China's request for two additional Beijing-New York/Washington flights tied to a planned Xi-Trump meeting, arguing Chinese carriers retain an unfair cost advantage through access to Russian airspace. U.S. carriers remain barred from Russian overflights, resulting in longer routes, higher fuel consumption and reduced competitiveness; a USDOT proposal to prohibit Chinese carriers from using Russian airspace on U.S. routes was shelved ahead of trade talks with China.

Analysis

This is not an earnings-moving event by itself, but it preserves a meaningful cost asymmetry on the highest-mileage transpacific city pairs. The pressure point is less absolute China revenue than network economics: UAL and DAL cannot match a lower-cost competitor’s fare without diluting system yield, while declining to match cedes premium-cabin feed and corporate-contract relevance. UAL has the greatest Pacific-network sensitivity; AAL’s weaker balance sheet makes even modest international-margin leakage disproportionately negative for its equity multiple.

Over the next 1-3 months, any conversion of limited/event authority into recurring capacity would be a negative read-through for U.S. carrier transpacific unit revenue, particularly if Chinese carriers add frequencies in price-sensitive economy cabins. The more important catalyst is whether the previously deferred overflight restriction reappears after bilateral talks; a credible implementation timeline would remove the foreign-carrier cost advantage and could support a relative rerating in UAL/DAL before the actual operational change. A near-term policy reversal is also a risk to any bearish airline positioning.

Consensus may overstate the direct impact because China remains a limited component of total earnings for the U.S. majors and constrained bilateral capacity can support fares. The underappreciated issue is strategic: persistent one-sided access can shift connecting traffic and corporate travel share over 6-18 months, reducing the profitability of broader Asia network investments. Treat this as a regulatory optionality trade, not a standalone directional catalyst.

Key Decisions for Investors

• No outright trade on the requested incremental flights; monitor DOT docket activity and Chinese-carrier schedule filings over the next 30-60 days. Escalate only if recurring authority is granted or announced capacity exceeds event-related service.
• If recurring Chinese expansion is approved without a Russian-overflight remedy, initiate a 3-month relative short UAL / long JETS position: UAL has above-average Pacific-network exposure while JETS diversifies idiosyncratic China-route risk. Target 5-8% relative downside; stop if UAL guides international unit revenue above consensus or DOT revives the restriction.
• On credible DOT action imposing equivalent overflight limits, buy DAL or UAL 6-month calls rather than common stock to express policy upside with defined downside. The thesis is a transpacific yield/margin normalization; exit if implementation is delayed beyond the stated effective date or bilateral negotiations explicitly exempt Chinese carriers.
• Maintain an underweight in AAL versus DAL for 6-18 months: any incremental long-haul pricing pressure is more damaging to a levered balance sheet and limits AAL’s ability to defend share through capacity or fare actions. Falsification is sustained international RASM outperformance plus deleveraging ahead of plan.